BICYCLE THERAPEUTICS RECOGNISED WITH MULTIPLE BIOTECH INDUSTRY AWARDS

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today announced that it has been recognised by Biotech and Money, a community of senior life science decision makers, as the Private Life Science Growth Company of the Year. In addition, the company received the award of Best Platform Technology at the World ADC Awards. Presented during the World ADC Conference, the award acknowledges the best linker or payload platform technology and is selected for the system’s novelty and originality as well as scientific and commercial validation of the platform.

Read More